Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00453206
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
Wake Forest University Health Sciences 66
Testing effectiveness (Phase 2)Ended earlyNCT01350258
What this trial is testing

Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps

Who this might be right for
Hematologic MalignanciesAcute LeukemiaMyelodysplastic Syndromes (MDS) Other Than RA or RARS Subtypes+4 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 8
Testing effectiveness (Phase 2)Study completedNCT00429143
What this trial is testing

A Two-Step Approach to Bone Marrow Transplant Using Cells From A Partially-Matched Relative

Who this might be right for
Hematologic Malignancies
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 27
Testing effectiveness (Phase 2)Study completedNCT01760655
What this trial is testing

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia With FLT3/ITD MutationAcute Myeloid Leukemia With Gene MutationsAcute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM+18 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 62
Testing effectiveness (Phase 2)Study completedNCT00185614
What this trial is testing

Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma

Who this might be right for
Blood CancerMultiple Myeloma
Wen-Kai Weng 63
Testing effectiveness (Phase 2)Active Not RecruitingNCT02323867
What this trial is testing

Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies

Who this might be right for
LeukemiaLymphomaMyelodysplasia
Children's Hospital of Philadelphia 140
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07808112
What this trial is testing

CSF-1R Inhibitor, Axatilimab, for Prevention of Acute and Chronic GVHD After HLA-Matched Related and Unrelated Donor Allogeneic Stem Cell Transplantation

Who this might be right for
Graft -Versus-host-disease
Medical College of Wisconsin 72
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT01384513
What this trial is testing

A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+44 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 40
Testing effectiveness (Phase 2)Looking for participantsNCT05805605
What this trial is testing

Allo HSCT Using RIC and PTCy for Hematological Diseases

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaBiphenotypic Acute Leukemia+15 more
Masonic Cancer Center, University of Minnesota 56
Testing effectiveness (Phase 2)WithdrawnNCT01620229
What this trial is testing

Brentuximab Vedotin After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Hematopoietic/Lymphoid Cancer
Fred Hutchinson Cancer Center
Not applicableLooking for participantsNCT06082947
What this trial is testing

ΑβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT)

Who this might be right for
Hematopoietic Stem Cell TransplantationHematologic Malignancy
Nationwide Children's Hospital 50
Early research (Phase 1)Study completedNCT00004232
What this trial is testing

Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Northwestern University
Not applicableStudy completedNCT01997918
What this trial is testing

Secondary Haplo HSCT for Relapse After Initial Allogeneic HSCT

Who this might be right for
Relapse of Hematological Malignancies
University Hospital Tuebingen 60
Not applicableEnded earlyNCT00301860
What this trial is testing

Donor Stem Cell Transplant Followed By Donor White Blood Cell Infusions in Treating Young Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphoma
University of California, San Francisco 8
Not applicableStudy completedNCT07116018
What this trial is testing

Psychoeducation for AlloHCT Caregivers

Who this might be right for
CancerCaregiversStem Cell Transplant+2 more
University Health Network, Toronto 17
Testing effectiveness (Phase 2)Ended earlyNCT01622556
What this trial is testing

Conditioning Treatment With Umbilical Cord Blood Transplant for Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
University of Virginia 6
Large-scale testing (Phase 3)UnknownNCT03236129
What this trial is testing

Allogeneic Immunotherapy for Hematological Malignancies by Selective Depletion of Regulatory T Cells

Who this might be right for
Hematological MalignanciesRegulatory T Cell DepletionRelapse
Assistance Publique - Hôpitaux de Paris 52
Testing effectiveness (Phase 2)Study completedNCT01814475
What this trial is testing

Study to Compare Busulfan-fludarabine With Thiotepa-fludarabine Regimen in Allogeneic Transplantation for Myelofibrosis

Who this might be right for
Myelofibrosis
Gruppo Italiano Trapianto di Midollo Osseo 62
Testing effectiveness (Phase 2)Study completedNCT03032783
What this trial is testing

A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing Toxicity

Who this might be right for
Hematopoietic and Lymphoid Cell Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 51
Next Page